account_balance
Investment manager · 13F filer · SEC CIK 1595855
Opaleye Management Inc.
Reported value$1.1Bas of Jun 30, 2026
Positions58 13 new, 9 sold out
Top 10 weight65%LQDA alone is 18%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
LQDA
Liquidia Corporation
17.7%Trimmed
ETON
Eton Pharmaceuticals INC
9.4%
HROW
Harrow INC
9.2%Trimmed
IRON
Disc Medicine INC
5.7%Added
URGN
Urogen Pharma Ltd
4.8%
APGE
Apogee Therapeutics INC
4.7%
MGTX
Meiragtx Hldgs PLC
4.3%Added
SLGL
Sol-gel Technologies Ltd
3.4%
RZLT
Rezolute INC
3.0%
TGTX
Tg Therapeutics INC
2.7%
48 others
35.2%
Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed